rs76992529

Variant summary

Our verdict is Pathogenic. The variant received 10 ACMG points: 13P and 3B. PM1PM5PP2PP5_Very_StrongBP4BS1_SupportingBS2_Supporting

The NM_000371.4(TTR):​c.424G>A​(p.Val142Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000888 in 1,614,082 control chromosomes in the GnomAD database, including 8 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. V142A) has been classified as Likely pathogenic.

Frequency

Genomes: 𝑓 0.0047 ( 5 hom., cov: 33)
Exomes 𝑓: 0.00049 ( 3 hom. )

Consequence

TTR
NM_000371.4 missense

Scores

3
7
7

Clinical Significance

Pathogenic/Likely pathogenic criteria provided, multiple submitters, no conflicts P:50O:1

Conservation

PhyloP100: 3.22

Publications

779 publications found
Variant links:
Genes affected
TTR (HGNC:12405): (transthyretin) This gene encodes one of the three prealbumins, which include alpha-1-antitrypsin, transthyretin and orosomucoid. The encoded protein, transthyretin, is a homo-tetrameric carrier protein, which transports thyroid hormones in the plasma and cerebrospinal fluid. It is also involved in the transport of retinol (vitamin A) in the plasma by associating with retinol-binding protein. The protein may also be involved in other intracellular processes including proteolysis, nerve regeneration, autophagy and glucose homeostasis. Mutations in this gene are associated with amyloid deposition, predominantly affecting peripheral nerves or the heart, while a small percentage of the gene mutations are non-amyloidogenic. The mutations are implicated in the etiology of several diseases, including amyloidotic polyneuropathy, euthyroid hyperthyroxinaemia, amyloidotic vitreous opacities, cardiomyopathy, oculoleptomeningeal amyloidosis, meningocerebrovascular amyloidosis and carpal tunnel syndrome. [provided by RefSeq, Aug 2017]
TTR Gene-Disease associations (from GenCC):
  • amyloidosis, hereditary systemic 1
    Inheritance: AD Classification: DEFINITIVE Submitted by: G2P
  • familial amyloid neuropathy
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • hereditary ATTR amyloidosis
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • heart conduction disease
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
  • ATTRV122I amyloidosis
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Pathogenic. The variant received 10 ACMG points.

PM1
In a hotspot region, there are 5 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 3 benign, 9 uncertain in NM_000371.4
PM5
Other missense variant is known to change same aminoacid residue: Variant chr18-31598656-T-C is described in ClinVar as Pathogenic/Likely_pathogenic. ClinVar VariationId is 1333466.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
PP2
Missense variant in the gene, where a lot of missense mutations are associated with disease in ClinVar. The gene has 108 curated pathogenic missense variants (we use a threshold of 10). The gene has 3 curated benign missense variants. Gene score misZ: 1.0149 (below the threshold of 3.09). Trascript score misZ: 1.5458 (below the threshold of 3.09). GenCC associations: The gene is linked to familial amyloid neuropathy, amyloidosis, hereditary systemic 1, ATTRV122I amyloidosis, hereditary ATTR amyloidosis, heart conduction disease.
PP5
Variant 18-31598655-G-A is Pathogenic according to our data. Variant chr18-31598655-G-A is described in ClinVar as Pathogenic/Likely_pathogenic. ClinVar VariationId is 13426.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP4
Computational evidence support a benign effect (MetaRNN=0.009103388). . Strength limited to SUPPORTING due to the PP5.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00467 (711/152230) while in subpopulation AFR AF = 0.0165 (687/41538). AF 95% confidence interval is 0.0155. There are 5 homozygotes in GnomAd4. There are 313 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting
BS2
High AC in GnomAd4 at 711 AD gene. Variant has AC lower than other variant known as pathogenic in the gene, so the strength is limited to Supporting.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000371.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TTR
NM_000371.4
MANE Select
c.424G>Ap.Val142Ile
missense
Exon 4 of 4NP_000362.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TTR
ENST00000237014.8
TSL:1 MANE Select
c.424G>Ap.Val142Ile
missense
Exon 4 of 4ENSP00000237014.4
TTR
ENST00000649620.1
c.424G>Ap.Val142Ile
missense
Exon 6 of 6ENSP00000497927.1
TTR
ENST00000858988.1
c.424G>Ap.Val142Ile
missense
Exon 6 of 6ENSP00000529047.1

Frequencies

GnomAD3 genomes
AF:
0.00467
AC:
710
AN:
152112
Hom.:
5
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0165
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00118
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.000622
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000147
Gnomad OTH
AF:
0.000956
GnomAD2 exomes
AF:
0.00113
AC:
283
AN:
251408
AF XY:
0.000670
show subpopulations
Gnomad AFR exome
AF:
0.0157
Gnomad AMR exome
AF:
0.000578
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000352
Gnomad OTH exome
AF:
0.000326
GnomAD4 exome
AF:
0.000494
AC:
722
AN:
1461852
Hom.:
3
Cov.:
31
AF XY:
0.000432
AC XY:
314
AN XY:
727234
show subpopulations
African (AFR)
AF:
0.0175
AC:
586
AN:
33480
American (AMR)
AF:
0.000827
AC:
37
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39698
South Asian (SAS)
AF:
0.000128
AC:
11
AN:
86258
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53388
Middle Eastern (MID)
AF:
0.000693
AC:
4
AN:
5768
European-Non Finnish (NFE)
AF:
0.0000261
AC:
29
AN:
1112006
Other (OTH)
AF:
0.000911
AC:
55
AN:
60394
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.474
Heterozygous variant carriers
0
45
90
136
181
226
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
22
44
66
88
110
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00467
AC:
711
AN:
152230
Hom.:
5
Cov.:
33
AF XY:
0.00421
AC XY:
313
AN XY:
74432
show subpopulations
African (AFR)
AF:
0.0165
AC:
687
AN:
41538
American (AMR)
AF:
0.00118
AC:
18
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5170
South Asian (SAS)
AF:
0.000415
AC:
2
AN:
4820
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10600
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000147
AC:
1
AN:
68014
Other (OTH)
AF:
0.000946
AC:
2
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
29
59
88
118
147
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00176
Hom.:
6
Bravo
AF:
0.00560
ESP6500AA
AF:
0.0175
AC:
77
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.00137
AC:
167
Asia WGS
AF:
0.000289
AC:
1
AN:
3478
EpiCase
AF:
0.00
EpiControl
AF:
0.0000593

ClinVar

ClinVar submissions as Germline
Significance:Pathogenic/Likely pathogenic
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
23
-
-
Amyloidosis, hereditary systemic 1 (24)
16
-
-
not provided (16)
2
-
-
Cardiovascular phenotype (2)
2
-
-
Hyperthyroxinemia, dystransthyretinemic;C2751492:Amyloidosis, hereditary systemic 1;C5779776:Carpal tunnel syndrome 1 (2)
2
-
-
TTR-related disorder (2)
1
-
-
Amyloidosis (1)
1
-
-
ATTRV122I amyloidosis (1)
1
-
-
Cardiomyopathy (1)
1
-
-
Charcot-Marie-Tooth disease (1)
1
-
-
Tip-toe gait (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.11
BayesDel_addAF
Benign
-0.15
T
BayesDel_noAF
Uncertain
0.020
CADD
Benign
18
DANN
Uncertain
1.0
DEOGEN2
Uncertain
0.42
T
Eigen
Uncertain
0.37
Eigen_PC
Benign
0.21
FATHMM_MKL
Uncertain
0.92
D
LIST_S2
Benign
0.74
T
MetaRNN
Benign
0.0091
T
MetaSVM
Uncertain
0.76
D
MutationAssessor
Pathogenic
3.0
M
PhyloP100
3.2
PrimateAI
Benign
0.34
T
PROVEAN
Benign
-0.48
N
REVEL
Pathogenic
0.65
Sift
Uncertain
0.023
D
Sift4G
Pathogenic
0.0
D
Polyphen
1.0
D
Vest4
0.27
MVP
0.94
MPC
0.39
ClinPred
0.065
T
GERP RS
4.3
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.31
gMVP
0.79
Mutation Taster
=66/34
disease causing (ClinVar)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs76992529; hg19: chr18-29178618; COSMIC: COSV99030963; COSMIC: COSV99030963; API